LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
70 hedge funds and large institutions have $335M invested in La Jolla Pharmaceutical Company in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
Holders
70
Holding in Top 10
3
Calls
$1.49M
Puts
$585K
Top Buyers
1 | +$11.6M | |
2 | +$5.2M | |
3 | +$4.11M | |
4 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.76M |
5 |
RI
RTW Investments
New York
|
+$1.77M |
Top Sellers
1 | -$12M | |
2 | -$5.08M | |
3 | -$3.78M | |
4 |
IHM
Iguana Healthcare Management
New York
|
-$2.97M |
5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.24M |